Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study.

Ricceri, Federica; Rosi, Elia; Di Cesare, Antonella; Scandagli, Ilaria; Fastame, Maria Thais; Prignano, Francesca

Ricceri, Federica; Rosi, Elia; Di Cesare, Antonella; Scandagli, Ilaria; Fastame, Maria Thais; Prignano, Francesca.

Afiliación

Ricceri F; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Rosi E; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Di Cesare A; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Scandagli I; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Fastame MT; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Prignano F; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.

J Dermatolog Treat ; 33(4): 1983-1985, 2022 Jun.

Article en En | MEDLINE | ID: mdl-33929274

Asunto(s)

Adalimumab; Biosimilares Farmacéuticos; Etanercept; Infliximab; Psoriasis; Inhibidores del Factor de Necrosis Tumoral; Adalimumab/efectos adversos; Adalimumab/uso terapéutico; Biosimilares Farmacéuticos/efectos adversos; Biosimilares Farmacéuticos/uso terapéutico; Fármacos Dermatológicos/efectos adversos; Fármacos Dermatológicos/uso terapéutico; Etanercept/efectos adversos; Etanercept/uso terapéutico; Humanos; Infliximab/efectos adversos; Infliximab/uso terapéutico; Necrosis/inducido químicamente; Necrosis/tratamiento farmacológico; Psoriasis/tratamiento farmacológico; Estudios Retrospectivos; Resultado del Tratamiento; Inhibidores del Factor de Necrosis Tumoral/efectos adversos; Inhibidores del Factor de Necrosis Tumoral/uso terapéutico; Factor de Necrosis Tumoral alfa/antagonistas & inhibidores

Palabras clave

Psoriasis; anti-TNF-alpha; biosimilar

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Biosimilares Farmacéuticos / Adalimumab / Infliximab / Etanercept / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: J Dermatolog Treat Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google